Press releases

December 21, 2022

Mayflower Bioventures Launches its First Spin-Out, Primera Therapeutics

Mayflower Bioventures Launches its First Spin-Out, Primera Therapeutics, in Strategic Collaboration with Cellectis to Develop a Gene Editing Platform to Treat Mitochondrial Diseases December 29, 2022 […]